Dr. Gonzalo Hortelano

About

Gene and cell therapy technologies provide a promising new avenue to treat medical conditions. Furthermore, the original aim of gene therapy, understood as the delivery of a functional gene in a patient who has a mutated one is being widen to include new aims such as the inhibition of genes of infectious pathogens, the overexpression of angiogenic or interleukin genes in patients who bear no mutations in those genes, gene editing or the engineering of immune cells to recognize a tumour antigen. My research is aimed at developing novel strategies for the delivery of genes and cells for medical therapeutic applications. As a common theme all these strategies use biomaterials to achieve its purpose. My laboratory has comprehensive experience encapsulating genetically engineered cells in hydro